Catalogo dei prodotti della ricerca

MERLI, Manuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.037
EU - Europa 5.150
AS - Asia 2.271
AF - Africa 547
SA - Sud America 79
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 26.092
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.638
IT - Italia 1.996
IN - India 835
DE - Germania 803
CN - Cina 693
SE - Svezia 656
SG - Singapore 640
FI - Finlandia 463
BJ - Benin 433
UA - Ucraina 405
RO - Romania 209
BZ - Belize 195
CA - Canada 170
BG - Bulgaria 168
GB - Regno Unito 143
IE - Irlanda 101
TG - Togo 84
AR - Argentina 63
FR - Francia 41
NL - Olanda 32
BE - Belgio 31
MX - Messico 31
RU - Federazione Russa 22
ES - Italia 21
AT - Austria 14
TR - Turchia 13
TN - Tunisia 12
IR - Iran 11
CH - Svizzera 9
EE - Estonia 9
KR - Corea 8
PK - Pakistan 8
TW - Taiwan 8
CL - Cile 7
ID - Indonesia 7
LK - Sri Lanka 6
MM - Myanmar 6
PL - Polonia 6
AE - Emirati Arabi Uniti 5
BR - Brasile 5
EU - Europa 5
LV - Lettonia 5
MY - Malesia 5
SC - Seychelles 5
ZA - Sudafrica 5
AL - Albania 4
GR - Grecia 4
HR - Croazia 4
TH - Thailandia 4
VN - Vietnam 4
AU - Australia 3
EG - Egitto 3
HK - Hong Kong 3
JP - Giappone 3
OM - Oman 3
CO - Colombia 2
GT - Guatemala 2
IL - Israele 2
NG - Nigeria 2
PH - Filippine 2
AZ - Azerbaigian 1
DZ - Algeria 1
EC - Ecuador 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
RS - Serbia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 26.092
Salva come PNG Salva come JPEG
Città #
Fairfield 2.820
Ashburn 1.382
Woodbridge 1.309
Chandler 1.089
Seattle 1.052
Houston 967
Cambridge 923
Wilmington 895
Ann Arbor 659
Princeton 572
Rome 534
Dearborn 523
San Jose 514
San Paolo di Civitate 464
Frankfurt am Main 440
Fasano 410
Plano 398
Beijing 362
Singapore 302
Lawrence 276
Fremont 273
Millbury 256
San Diego 226
Belize City 195
Horia 186
Dallas 179
Boston 176
Sofia 168
Jacksonville 165
Bremen 138
Andover 114
Saint Louis 112
Ottawa 109
Helsinki 100
Dublin 97
Lomé 84
New York 82
Norwalk 80
Atlanta 71
San Mateo 70
Stockholm 69
Des Moines 67
Chicago 65
Federal 62
Falls Church 55
Los Angeles 55
Milan 54
Toronto 52
Columbus 51
Hefei 50
Boardman 49
Washington 37
Nanjing 36
Bühl 35
Mannheim 33
Brussels 31
Southend 28
Kunming 26
Phoenix 24
Jinan 22
Nanchang 21
Auburn Hills 18
Guangzhou 17
Bologna 16
Naples 16
Mexico City 15
Indiana 12
Kairouan 12
Vienna 12
Baotou 11
Fuzhou 11
Hebei 11
Redwood City 11
Shanghai 11
Acerra 10
Buffalo 10
Grafing 10
Padova 10
Santiago de Compostela 10
London 9
Shenyang 9
Tallinn 9
Chengdu 8
Istanbul 8
Moscow 8
Turin 8
Zhengzhou 8
Kilburn 7
Berlin 6
Changsha 6
Florence 6
Genzano Di Roma 6
Leawood 6
Montréal 6
Romainville 6
Rotterdam 6
Teramo 6
Yangon 6
Ancona 5
Ankara 5
Totale 20.061
Salva come PNG Salva come JPEG
Nome #
Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy 195
Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis 171
Nutrition in cirrhosis: Dos and Don'ts 168
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 136
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 134
The multidisciplinary support in preventing alcohol relapse after liver transplantation: a single centre experience 129
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 126
MRI reveals different Crohn's disease phenotypes in children and adults 121
Management of Hepatic Encephalopathy as an Inpatient 119
Prevalence and impact of sarcopenia in non-cirrhotic portal hypertension 119
Skeletal muscle myopenia in mice model of bile duct ligation and carbon tetrachloride-induced liver cirrhosis 109
Evidence of Persistent Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy 104
High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: A case-control study 103
REGULATION OF LIVER GRAFT CHOLESTEROL SYNTHESIS AND UPTAKE AFFECTS THE OUTCOME OF HUMAN LIVER TRANSPLANTATION 102
Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: Results of a randomized controlled trial 102
A low muscle mass increases mortality in compensated cirrhotic patients with sepsis 101
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 101
Muscle alterations are associated with minimal and overt hepatic encephalopathy in patients with liver cirrhosis 101
EASL Clinical Practice Guidelines on nutrition in chronic liver disease 100
Failure of hepatitis B vaccination to induce either humoral or cellular immune response after liver transplantation for hepatitis B related cirrhosis 99
No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt 99
Donor small-droplet macrovesicular steatosis affects liver transplant outcome in HCV-negative recipients 99
Semeiotica Medica e Metodologia Clinica, 3ª ed 99
Impact of Anti-Hepatitis B Core-Positive Donors in Liver Transplantation: A Survival Analysis 98
Donor/recipient body surface area ratio as a novel predictor of graft survival after deceased donor liver transplantation 98
BACTERIAL INFECTIONS AND SEPSIS ACUTELY DETERIORATE LIVER FUNCTION IN CIRRHOTIC PATIENTS: A PROSPECTIVE STUDY 96
Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factors 95
Is the multidisciplinary support effective in preventing alcohol relapse after liver transplantation? 95
Intraoperative histological ischemia–reperfusion injury assessment but not clinical early allograft dysfunction predicts graft loss only in HCV positive recipients submitted to liver transplant 95
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology 95
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial 94
Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis 94
Beta-blokers in patients with cirrhosis and infection: don't blame too soon. 93
CARBON TETRACHLORIDE-INDUCED EXPERIMENTAL CIRRHOSIS IN THE RAT - A REAPPRAISAL OF THE MODEL 93
CHRONIC RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION: RISK FACTORS AND A NEW PREDICTIVE SCORE 93
Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation 93
Cirrhotic patients are at risk for health care-associated bacterial infections. 92
Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt 92
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe 91
Cognitive impairment predicts the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt 91
Occurrence of Chronic Renal Failure in Liver Transplantation: Monitoring of Pre- and Posttransplantation Renal Function 91
Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients 90
A Simplified Psychometric Evaluation for the Diagnosis of Minimal Hepatic Encephalopathy 90
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 90
Ongoing prothrombotic state in the portal circulation of cirrhotic patients 89
REGULATION OF LIVER GRAFT CHOLESTEROL SYNTHESIS AND UPTAKE AFFECTS THE OUTCOME OF HUMAN LIVER TRANSPLANTATION 89
Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis 89
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide 89
Donor liver small droplet macrovesicular steatosis is associated with reduced graft survival after liver transplantation 89
The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease 89
Long-term effect of liver transplantation on cirrhotic autonomic cardiac dysfunction 88
Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. 88
Chronic renal dysfunction after liver transplantation: Incidence and risk factors 88
Does nutritional status influence the outcome in patients undergoing liver transplantation in the “MELD” era? 88
A practical approach to nutritional screening and assessment in cirrhosis 87
DONOR/RECIPIENT BODY SURFACE AREA RATIO AS A NOVEL PREDICTOR OF GRAFT SURVIVAL AFTER DECEASED DONOR LIVER TRANSPLANTATION 87
Sarcopenia in non-alcoholic fatty liver disease: targeting the real culprit? 86
The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis. 86
Sarcopenic obesity in fatty liver 86
Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease 85
Donor arterial oxygen pressure is a major determinant of early post-operative adverse events in adult liver transplant recipients 85
Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt 85
Proton pump inhibitors are associated with minimal and overt hepatic encephalopathy and increased mortality in patients with cirrhosis 85
Dietary and nutritional indications in hepatic encephalopathy 84
MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective 84
May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease? 84
Combined Liver-Kidney Transplantation in Polycystic Disease: Case Reports 84
The impact of multidisciplinary support to alcohol misusers at risk of alcohol relapse after liver transplantation 83
Donor-to-recipient gender match in liver transplantation. A systematic review and meta-analysis 83
Atorvastatin-Induced Prolonged Cholestasis with Bile Duct Damage 82
Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence 82
Predictive Factors of Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Multivariate Analysis 82
ANTIVIRAL TREATMENT MAY IMPROVE THE OUTCOME OF PATIENTS WITH RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 82
Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis 82
Acute Renal Failure in Liver Transplant Recipients: Role of Pretransplantation Renal Function and 1-Year Follow-Up 81
Outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma 81
REGULATION OF LIVER GRAFT CHOLESTEROL SYNTHESIS AND UPTAKE AFFECTS THE OUTCOME OF HUMAN LIVER TRANSPLANTATION 81
Fluctuations of estimated glomerular filtration rate outside kidney disease improving global outcomes diagnostic criteria for acute kidney injury in end-stage liver disease outpatients and outcome postliver transplantation 81
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 81
QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt 80
Clotting activation after transjugular intrahepatic portosystemic stent shunt 80
Conversion From Twice-Daily to Once-Daily Tacrolimus Administration in Liver Transplant Patient 80
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results. 80
RIFLE Criteria and Hepatic Function in the Assessment of Acute Renal Failure in Liver Transplantation 80
Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice 80
A cost analysis of a broad-spectrum antibiotic therapy in the empirical treatment of health care-associated infections in cirrhotic patients 80
Polyunsaturated fatty acids balance affects platelet NOX2 activity in patients with liver cirrhosis 80
CHRONIC RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION: RISK FACTORS AND A NEW PREDICTIVE SCORE 80
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (tips): PTFE-covered stent grafts versus bare stents 80
Sarco-Model: a score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 80
OLDER DONOR AGE IS ASSOCIATED WITH INCREASED DONOR OXIDATIVE STRESS AND FAILURE TO RESTORE BASAL PROTEIN GRAFT CONTENT AFTER ISCHEMIA REPERFUSION IN HUMAN LIVER TRANSPLANTATION 79
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey 79
Do We Really Need Alternatives to Polymorphonuclear Cells Counting in Ascitic Fluid? 79
Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients 79
EFFECT OF RIBAVIRIN PRE-TREATMENT ON EARLY VIROLOGICAL RESPONSE OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 79
Differential VEGF-A protein expression between small HCC and cirrhosis at distance from the tumor correlates with serum VEGF-A and alpha-fetoprotein 79
Ischemic Damage Represents the Main Risk Factor for Biliary Stricture After Liver Transplantation: A Follow-Up Study in a Danish Population 79
ESPEN guideline on clinical nutrition in liver disease 79
Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice 79
Modification of cardiac function in cirrhotic patients with and without ascites 78
Totale 9.340
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.712
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.403 0 205 53 261 573 2.988 976 732 707 464 280 164
2020/20212.484 251 250 82 372 61 114 45 199 208 335 112 455
2021/20224.708 64 225 439 130 593 105 100 495 727 348 578 904
2022/20234.982 941 1.046 407 953 404 371 51 193 381 51 133 51
2023/20242.489 125 291 117 179 235 505 97 168 20 324 214 214
2024/2025276 239 37 0 0 0 0 0 0 0 0 0 0
Totale 27.333